Abstract
Rationale
Little is known about relapse among non-daily, intermittent smokers (ITS), who have difficulty quitting, despite a lack of dependence.
Objectives
To analyze situations associated with temptations to smoke and smoking lapses among ITS trying to maintain abstinence.
Methods
Participants were 130 initially abstinent ITS in the placebo arm of a smoking cessation study. EMA data captured participants’ situations and states in temptations (n = 976), including those that eventuated in lapses (n = 147), for up to 6 weeks. Randomly timed assessments assessed background states (n = 11,446). Participants also reported coping performed to prevent lapses. Multilevel analyses compared temptations to background situations, and lapse episodes to resolved temptations.
Results
Temptations were marked by exposure to smoking cues, including others smoking, lax smoking restrictions, and alcohol consumption, as well as more negative affect. Lapses did not differ from resolved temptations in craving intensity, but were more often associated with smoking cues and availability of cigarettes, alcohol consumption, and worse affect, and were more often attributed to good moods. Both behavioral and cognitive coping responses were associated with avoiding lapsing, but behavioral coping had much larger effects. The effects of affective distress on lapse risk were mediated by its effects on coping.
Conclusions
Smoking cues play a major role in ITS’ temptations and lapses, perhaps indicating a degree of behavioral dependence. Affective distress also played a role in ITS lapses, undermining the idea that the affective distress seen in daily smokers’ lapses is due to nicotine withdrawal. The data reinforce the important role of coping in preventing lapses.
Similar content being viewed by others
References
Baer JS, Kamarck T, Lichtenstein E, Ransom CC Jr (1989) Prediction of smoking relapse: analyses of temptations and transgressions after initial cessation. J Consult Clin Psychol 57:623–627
Baker TB, Piper ME, McCarthy DE, Majeskie MR, Fiore MC (2004) Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev 111:33–51
Bold KW, McCarthy DE, Minami H, Yeh VM, Chapman GB, Waters AJ (2016) Independent and interactive effects of real-time risk factors on later temptations and lapses among smokers trying to quit. Drug Alcohol Depen 158:30–37
Bolman C, Verboon P, Thewissen V, Boonen V, Soons K, Jacobs N (2018) Predicting smoking lapses in the first week of quitting: an ecological momentary assessment study. J Addict Med 12:65–71
Borland R (1990) Slip-ups and relapse in attempts to quit smoking. Addict Behav 15:235–245
Businelle MS, Ma P, Kendzor DE, Frank SG, Wetter DW, Vidrine DJ (2016) Using intensive longitudinal data collected via mobile phone to detect imminent lapse in smokers undergoing a scheduled quit attempt. J Med Internet Res 18:e275
Drobes DJ, Meier EA, Tiffany ST (1994) Assessment of the effects of urges and negative affect on smokers’ coping skills. Behav Res Ther 32:165–174
Edwards AC, Kendler KS (2011) Nicotine withdrawal-induced negative affect is a function of nicotine dependence and not liability to depression or anxiety. Nicotine Tob Res 13:677–685
Ferguson SG, Shiffman S (2009) The relevance and treatment of cue-induced cravings in tobacco dependence. J Subst Abus Treat 36:235–243
Ferguson SG, Shiffman S (2014) Effect of high-dose nicotine patch on craving and negative affect leading up to lapse episodes. Psychopharmacology 231:2595–2602
Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T (2018) Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev 5:CD000146
Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO (1991) The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 86:1119–1127
Hedeker D, du Toit SHC, Demirtas H, Gibbons RD (2018) A note on marginalization of regression parameters from mixed models of binary outcomes. Biometrics 74:354–361
Hughes JR (2007) Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res 9:315–327
Hughes JR, Hatsukami D (1986) Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43:289–294
Kassel JD, Stroud LR, Paronis CA (2003) Smoking, stress, and negative affect: correlation, causation, and context across stages of smoking. Psychol Bull 129:270–304
Lam CY, Businelle MS, Aigner CJ, McClure JB, Cofta-Woerpel L, Cinciripini PM, Wetter DW (2014) Individual and combined effects of multiple high-risk triggers on postcessation smoking urge and lapse. Nicotine Tob Res 16:569–575
Marlatt GA, Gordon JR (1985) Relapse prevention: maintenance strategies in the treatment of addictive behaviors Guilford press, New York
Minami H, Yeh VM, Bold KW, Chapman GB, McCarthy DE (2014) Relations among affect, abstinence motivation and confidence, and daily smoking lapse risk. Psychol Addict Behav 28:376–388
Muraven M, Baumeister RF (2000) Self-regulation and depletion of limited resources: does self-control resemble a muscle? Psychol Bull 126:247–259
Muraven M, Tice DM, Baumeister RF (1998) Self-control as limited resource: regulatory depletion patterns. J Pers Soc Psychol 74:774–789
O'Connell KA, Martin EJ (1987) Highly tempting situations associated with abstinence, temporary lapse, and relapse among participants in smoking cessation programs. J Consult Clin Psychol 55:367–371
O'Connell KA, Gerkovich MM, Cook MR, Shiffman S, Hickcox M, Kakolewski KE (1998) Coping in real time: using ecological momentary assessment techniques to assess coping with the urge to smoke. Res Nurs Health 21:487–497
O'Connell KA, Schwartz JE, Shiffman S (2008) Do resisted temptations during smoking cessation deplete or augment self-control resources? Psychol Addict Behav 22:486–495
Reyes-Guzman CM, Pfeiffer RM, Lubin J, Freedman ND, Cleary SD, Levine PH, Caporaso NE (2017) Determinants of light and intermittent smoking in the United States: results from three pooled national health surveys. Cancer Epidemiol Biomark Prev 26:228–239
Sayette MA, Hufford MR (1997) Effects of smoking urge on generation of smoking-related information. J Appl Soc Psychol 27:1395–1405
Sayette MA, Martin CS, Wertz JM, Shiffman S, Perrott MA (2001) A multi-dimensional analysis of cue-elicited craving in heavy smokers and tobacco chippers. Addiction 96:1419–1432
Schane RE, Glantz SA, Ling PM (2009) Social smoking implications for public health, clinical practice, and intervention research. Am J Prev Med 37:124–131
Shiffman S (1982) Relapse following smoking cessation: a situational analysis. J Consult Clin Psychol 50:71–86
Shiffman S (1984) Coping with temptations to smoke. J Consult Clin Psychol 52:261–267
Shiffman S (1986) A cluster-analytic classification of smoking relapse episodes. Addict Behav 11:295–307
Shiffman S, Waters AJ (2004) Negative affect and smoking lapses: a prospective analysis. J Consult Clin Psychol 72:192–201
Shiffman S, Gnys M, Richards TJ, Paty JA, Hickcox M, Kassel JD (1996a) Temptations to smoke after quitting: a comparison of lapsers and maintainers. Health Psychol 15:455–461
Shiffman S, Paty JA, Gnys M, Kassel JA, Hickcox M (1996b) First lapses to smoking: within-subjects analysis of real-time reports. J Consult Clin Psychol 64:366–379
Shiffman S, Balabanis MH, Gwaltney CJ, Paty JA, Gnys M, Kassel JD, Hickcox M, Paton SM (2007) Prediction of lapse from associations between smoking and situational antecedents assessed by ecological momentary assessment. Drug Alcohol Depen 91:159–168
Shiffman S, Stone AA, Hufford MR (2008) Ecological momentary assessment. Annu Rev Clin Psychol 4:1–32
Shiffman S, Dunbar MS, Scholl SM, Tindle HA (2012a) Smoking motives of daily and non-daily smokers: a profile analysis. Drug Alcohol Depen 126:362–368
Shiffman S, Ferguson SG, Dunbar MS, Scholl SM (2012b) Tobacco dependence among intermittent smokers. Nicotine Tob Res 14:1372–1381
Shiffman S, Dunbar M, Kirchner T, Li X, Tindle H, Anderson S, Scholl S (2013a) Smoker reactivity to cues: effects on craving and on smoking behavior. J Abnorm Psychol 122:264–280
Shiffman S, Dunbar MS, Kirchner TR, Li X, Tindle HA, Anderson SJ, Scholl SM, Ferguson SG (2013b) Cue reactivity in non-daily smokers: effects on craving and on smoking behavior. Psychopharmacology 226:321–333
Shiffman S, Dunbar MS, Li X, Scholl SM, Tindle HA, Anderson SJ, Ferguson SG (2014a) Smoking patterns and stimulus control in intermittent and daily smokers. PLoS One 9:e89911
Shiffman S, Dunbar MS, Li X, Scholl SM, Tindle HA, Anderson SJ, Ferguson SG (2014b) Craving in intermittent and daily smokers during ad libitum smoking. Nicotine Tob Res 16:1063–1069
Shiffman S, Dunbar MS, Tindle HA, Ferguson SG (2015a) Nondaily smokers’ experience of craving on days they do not smoke. J Abnorm Psychol 124:648–659
Shiffman S, Dunbar MS, Ferguson SG (2015b) Stimulus control in intermittent and daily smokers. Psychol Addict Behav 29:847–855
Shiffman S, Scholl SM, Mao J, Ferguson SG, Hedeker D, Primack B, Tindle HA (2019) Using nicotine gum to assist non-daily smokers in quitting: a randomized clinical trial. Nicotine Tob Res
Stone AA, Shiffman S (1994) Ecological momentary assessment (EMA) in behavioral medicine. Ann Behav Med 16:199–202
Sussman S, Sussman AN (2011) Considering the definition of addiction. Int J Environ Res Public Health 8:4025–4038
Tiffany ST (1990) A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes. Psychol Rev 97:147–168
Tiffany ST, Hakenewerth DM (1991) The production of smoking urges through an imagery manipulation: psychophysiological and verbal manifestations. Addict Behav 16:389–400
Tindle HA, Shiffman S (2011) Smoking cessation behavior among intermittent smokers versus daily smokers. Am J Public Health 101:e1–e3
Van Zundert RM, Kuntsche E, Engels RC (2012) In the heat of the moment: alcohol consumption and smoking lapse and relapse among adolescents who have quit smoking. Drug Alcohol Depen 126:200–205
Zou Z, Wang H, d’Oleire Uquillas F, Wang X, Ding J, Chen H (2017) Definition of substance and non-substance addiction. Adv Exp Med Biol 1010:21–41
Acknowledgments
The authors are grateful to Brian Primack for medical and administrative oversight and consultation; Allison Brown for assistance overseeing the study; to Jessica Manriquez Richard, Jessica Cheng, Christina Warner, and Jacob Burns, research assistants who conducted research sessions; to James Moorehead for data management and preparation; to Alexsys Hoesch for administrative assistance; and to support provided by the National Institute on Drug Abuse (P30 DA012393) and the National Center for Research Resources (S10 RR026437) for laboratory resources at the University of California, San Francisco. We also appreciate the contributions of members of the study Data and Safety Monitoring Board, Peter Callas (University of Vermont), Jonathan Foulds (Pennsylvania State University), and John Hughes (University of Vermont, Chair).
Funding
This work was supported by a grant (R01 DA034629) to H. Tindle and B. Primack from the National Institute on Drug Abuse at the National Institutes of Health (NIH). NIH had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
At the time of this study and analysis, SS, through Pinney Associates, consulted on tobacco cessation and harm reduction (including nicotine replacement therapy and digital vapor products; by contract, combusted cigarettes are excluded) to Niconovum USA, RJ Reynolds Vapor Company, and RAI Services Company, all subsidiaries of Reynolds American, Inc. and British American Tobacco. Previously, SS consulted to NJOY on e-cigarettes, and to GlaxoSmithKline Consumer Healthcare on smoking cessation medications and treatments, including nicotine gum. Currently, SS and Pinney Associates consult to JUUL Labs on harm reduction. SS holds patents for a novel nicotine gum that is not under commercial development. HAT provided input to Achieve Life Sciences regarding study design for a future possible cessation trial of cytisine, and has led or co-led studies using smoking cessation medication donated by the manufacturer (e.g., Pfizer). SGF has worked as a consultant to GlaxoSmithKline Consumer Healthcare and Chrono Therapeutics on matters relating to smoking cessation, has received researcher-initiated project grant funding, and travel funds, from Pfizer, and has served on an advisory board for Johnson & Johnson. Other authors report no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 42 kb)
Rights and permissions
About this article
Cite this article
Shiffman, S., Scholl, S.M., Mao, J. et al. Ecological momentary assessment of temptations and lapses in non-daily smokers. Psychopharmacology 237, 2353–2365 (2020). https://doi.org/10.1007/s00213-020-05539-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-020-05539-3